Coronavirus: European Commission gives conditional marketing authorisation for AstraZeneca vaccine against COVID-19

date: 01/02/2021

The European Commission granted a conditional marketing authorisation for the AstraZeneca vaccine against COVID-19. The Commission is following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). 

More information
Press release of the European Commission
Coronavirus: EMA gives positive recommendation for AstraZeneca vaccine
COVID-19 vaccines
Questions and answers on COVID-19 vaccines (available in Dutch or French)

Last updated on 05/02/2021